Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKC/Gal-3 signaling pathway attenuates adverse cardiac fibrosis, following myocardial infarction
Event:
Heart Failure 2018
Topic:
Experimental Heart Failure
Session:
Chronic Heart Failure – Pathophysiology and Mechanisms
